Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year

Alzamend Neuro Inc ALZN received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for…

Related Keywords

Stephan Jackman ,Alzamend Neuro Inc ,Chief Executive Officer ,News ,Ggregator ,Reaking News ,Uration ,Media ,